Genmab
Aktiesnakken
Genmab
TESLA
NOVO
Forsvarsaktier
Bavarian Nordic
Amerikanske aktier
Gubra
Zealand Pharma
Biotek-snakken
Embla Medical
Vestas
BITCOIN
ExpreS2ion
AMBU
Hansa Biopharma
Politiksnakken
Smallcap og First North aktier
Medico
GN Store Nord
Pharma
Shipping
Ennogie
Laks
Grønne Aktier
|
26/10 11:09 af E L |
GEN1046 could be the jackpot if it works as good as Jan thinks... but it will still take some time; i don't think the data in november will be able to show us the full potential yet
|
|
|
26/10 11:00 af GeorgeBest |
Specielt epco og GEN1046 er ekstremt vigtige da Genmabs ejerandel er 50%
|
|
|
26/10 10:58 af GeorgeBest |
På lang sigt skal aktien up up and away. Pga epco, GEN1046, Amivantamab, Kesimpta. Genmab går fra at være en one trick pony, til et multiblockbuster biotech selskab
|
|
|
26/10 10:50 af Vitus |
Er der ellers nogle holdninger til aktien :-)
|
|
|
26/10 10:21 af Plimsoller |
Still doesn't work after closing the browser, but I will reboot after work. Thanks for your help :-)
|
|
|
26/10 10:18 af E L |
turned nicely on the 2194 Thursday low, let's see if it can turn into a small double bottom
|
|
|
26/10 10:17 af E L |
just close your browser & open again, or refresh page and should be fine
|
|
26/10 10:13 af troldmanden |
tror det er noget med når man ikke har haft PC slukket og den blot er i dvale. Uret viser også stadig sommertid i chatten hos mig
|
|
26/10 10:10 af Helge Larsen/PI-redaktør |
Her virker det fint på alle enheder. :-)
|
|
|
26/10 09:58 af Plimsoller |
Mon PC tid er fin, men tiden på chatten er ikke. Jeg genstarter når jeg får tid. Tak for info :-)
|
|
|
26/10 09:57 af Plimsoller |
Jeg sidder på Frederiksberg, så det tror jeg ikke :-)
|
|
|
26/10 09:52 af Plimsoller |
Tidsangivelserne på beskederne er en time foran. Måske er det kun på min skærm?
|
|
|
26/10 09:40 af Helge Larsen/PI-redaktør |
Hvilket Plimsoller...Uret funker fint i chatten?
|
|
|
26/10 09:19 af transalp |
Go morgen.. :)
|
|
|
26/10 08:06 af Plimsoller |
Jeg tror at du skal have lavet det om til vintertid Helge :-)
|
|
|
26/10 08:05 af Plimsoller |
God morgen :-)
|
|
|
26/10 07:11 af Helge Larsen/PI-redaktør |
God morgen. :-)
|
|
|
25/10 11:22 af E L |
ah, ok, misundertanding solved ;-) we are on the same line then
|
|
25/10 10:45 af Bulder |
Am I misunderstanding you? I think belamaf will not play any role because of eye problem.
|
|
|
25/10 10:20 af E L |
ok. i judged that differently, thought it could be a major problem. We'll just have to beat them on efficacy then ;)
|
|
|
25/10 10:08 af Bulder |
Yes, I think it will not play any role in the earlier lines. A bit like Selinexor.
|
|
|
25/10 08:58 af E L |
@Bulder , that wouldn't make any difference for the eye problems I imagine, that would probaby be the same for new jpatients?
|
|
|
25/10 08:36 af Helge Larsen/PI-redaktør |
God morgen. :-)
|
|
|
24/10 17:05 af Helge Larsen/PI-redaktør |
ANMELDELSE - BOBLER, BULLSHIT OG BØRSFEST : (link)
|
|
| ||
|
|
24/10 16:00 af Bulder |
.. refractory to these agents.
|
|
|
24/10 15:59 af Bulder |
... "all patients were exposed to bortezomib, lenalidomide, pomalidomide and daratumumab, and 80% of patients were exposed to carfilzomib." Thus for heavily pretreated pt
s refrsc
|
|
|
24/10 15:12 af E L |
table 3: (link) Keratopathy 96% any grade, 75% (!) grade 3 or 4
|
|
|
24/10 15:08 af E L |
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study (link)
|
|
|
24/10 09:45 af E L |
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab (link)
|
|
|
24/10 09:07 af Helge Larsen/PI-redaktør |
Stoxx: Europæiske health care aktier fortsat under pres pgr af ventet Biden sejr(link)
|
|
|
23/10 21:15 af GeorgeBest |
|
|
|
23/10 21:14 af GeorgeBest |
A Phase 1/2, Open-Label, Dose-Escalation
Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma
|
|
|
23/10 17:36 af Helge Larsen/PI-redaktør |
Genmab
@Genmab
·
2 t
Close collaboration with top research institutions is part of our DNA at Genmab. We are excited to announce our new partnership with @PrincetonChem
, which will pair experts in academia and our researchers to explore new areas of antibody research: (link)
|
|
|
23/10 17:31 af Helge Larsen/PI-redaktør |
I lige måde. :-)
|
|
|
23/10 14:00 af E L |
yes, it will be for the next generation i think, Hexabody-CD38 will be tested in DLBCL
|
|
|
23/10 13:56 af Bulder |
Men bortset fra det, så blev dara jo klinisk testet i NHL for år tilbage med skuffelse til følge. Tvivler på, det bliver taget op igen. (link)
|
|
|
23/10 13:40 af DevOp |
anything below 7-8% after a week like this is discarded :-)
|
|
23/10 13:34 af nohope |
He
xaneken 3,8% ?
|
|
|
23/10 13:23 af E L |
;-)
|
|
|
23/10 13:20 af Bullish |
I volunteer for the control group :)
|
|
|
23/10 13:17 af E L |
Friday rumour is that you will be able to mix Hexabody-CD38 into a beer bottle. It will be a real breaktrough in drug administration. You heard it here first!
|
|
|
23/10 13:14 af GeorgeBest |
:-)
|
|
|
23/10 13:12 af Bulder |
De er begge sc den ene i maven - den anden i låret. Hvor svært kan det være?
|
|
|
23/10 13:12 af GeorgeBest |
Selvfølgelig
|
|
|
23/10 13:11 af Bulder |
Hvorfor ikke kombineres med epco?
|
|
|
23/10 13:04 af E L |
(you know you already posted this before , right? ;-) )
|
|
|
23/10 13:04 af E L |
or DuoHexabody-CD37...
|
|
|
23/10 13:01 af GeorgeBest |
Nåja, sà skal dara konkurrere med epco :-)
|
|
|
23/10 12:29 af Helge Larsen/PI-redaktør |
Tusinde tak for info GTG. :-)
|
|
|
23/10 11:51 af gentogen |
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens
|